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Background: Melorheostosis is quite a rare bone disease with still unclear ethiology. Although multifocal affection
is highly debilitating with unfavorable prognosis, there is no clear consensus about therapeutical approach. There is
still insufficient evidence in the literature for almost a century after the first description.
Affected bone has a typical appearance of melting wax. Diagnosis is usually incidental with pain as a leading
symptom. Diagnosis itself is relatively easy, routine X-ray examination is sufficient. Even though it could be easily
overlooked and mistaken with other diseases. Melorheostosis is incurable, the therapy is mostly focused on
maintaining patient quality of life.
Presented case is unique in terms of extent of the affection (index finger, metacarp shaft, carpal bones, forearm,
humerus and whole scapula) in combination with osteopoikilotic islands in other 3 regions (vertebrae, manubrium
sterni and left collar bone). Currently there is only one such a case published in the literature (Campbell), but
without osteopoikilotic islands.
Case presentation: Melorheostosis was diagnosed in 26-year old female after injury as an incidental finding. This
was quite surprising as the patient already suffered by limited movement in the upper limb and pain before the injury.
Detailed examination were performed to confirm the diagnosis, no family history was found. Pharmacotherapy with
bisphosphonates, non-steroidal antirheumatics and vasodilatans/rheologic drugs seemed to be effective to maintain
the relatively good quality of patient life and good performance in daily routine. Questionable is further development
of patient performance status and sustainability of conservative treatment in the long term follow up.
Conclusion: Conservative treatment with bisphopshonates and COX-2 inhibitors in combination with naftidrofuryl can
delay surgery solution.
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Melorheostosis is a rare bone disease. Only about 300
cases have been reported worldwide [1]. The etiology is
still unknown. It is a developmental anomaly of bone
formation with the evidence of inheritance. The small
part of patients have mutations in LEMD3 group, but
this mutations was not present in most of the cases.
This anomaly was firstly described in 1922 by Leri and
Joany [2]. Typical for melorheostosis is a presence of
bone sclerosis with a linear pattern mainly affecting the
cortex of tubular bones which is identifiable by plain* Correspondence: vyskocil@fnplzen.cz
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unless otherwise stated.radiography [3]. Melorheostosis can occur at any age
and both sexes are affected equally.
The linear hyperostosis of cortex can extend and affect
medullar canal and periosteum resembling a typical
“melting wax” appearance of the affected bone [4]. Hy-
perostosis is very often accompanied by hyperplasia
and abnormalities of adjacent connective tissues [5].
Melorheostosis may be asymptomatic for a long time
but often leads to joint contractures, swelling, stiffness
and chronic pain [6]. Peak age of diagnosis is between
5 and 20 years [7].
Besides radiographic changes melorheostosis has 9
typical signs [8]: thickening of outer layer of bone, skin
affection, intermittent joint swelling, joint pain, limb de-
formity, nerve oppression, pain, paresthesia and reducedl. This is an Open Access article distributed under the terms of the Creative
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soft tissue lesions such as linear scleroderma, vascular
malformations, hemangioma, neurofibromatosis, arterial
aneurysm, tuberous sclerosis and focal subcutaneous
fibrosis [9].
There are 2 theories for melorheostosis etiology: (a)
early embryonic infection of a sensory nerve inducing
the changes in sclerotome [10] and (b) concept of “mo-
saicism” which can better explain an asymmetric seg-
mental pattern with variable expressivity and equal
gender ratio of the disease [11].
Case presentation
26-year old female patient underwent surgery of a cleft
palate at the age of 5 years, later she had no significant
health issue. Melorheostosis was diagnosed incidentally
by X-ray after shoulder injury in sport.Figure 1 CT of left hand and forearm. Diffuse thickening and
sclerotisation on index finger and II. metacarp shaft. The lesion is
less aparent at the I. metacarp and on some carpal bones. There is
diffusely enlarged sclerotic radius and humerus without ulna bridging.
Whole scapula on the left side is also affected. The cavities on the
affected bones are completely filled with the sclerotic bone.Clinical examination showed reduced joint abduction
60 degress in the shoulder, further movement was
possible only in scapula, movement range in the elbow
was limited to 20 degrees, in radiocarpal joint was volar
flexion up to 40 degrees, dorsal flexion 0, pronation and
supination was also 0. The patient reported pain in the
whole upper limb at rest. Osteopoikilotic islands were
identified in the body of third cervical vertebra and also
in the right collar bone and sternum manubrium. CT of
the upper limbs and upper chest was performed without
contrast tracer. There was no family history of melor-
heostosis found.
Diffuse thickening and sclerotisation was identified on
index finger, II. metacarp shaft on the left hand, the le-
sion was less aparent at the I. metacarp of the left hand
and on some carpal bones (Figure 1). There was diffusely
enlarged sclerotic radius, humerus and the scapula on
the left side. The cavities on affected bones were com-
pletely filled with the sclerotic bone. Small sclerotic
focus was in the ventral part of C3 vertebral body - size
7 mm (Figure 2), there was also a small island in the left
manubrium sternum and in the sternal part of the left
collarbone. The finding corresponded to melorheostosis
Léri. Thickness of patient’s left scapula was up to
31 mm, the contralateral scapula was unaffected with
thickness of 2–3 mm. The cortex of both collarbone and
ribs had slightly higher bone density. The skull was with-
out pathological finding.
Bone scintigraphy showed normal level of overall
metabolic activity in the skeleton. Significant, locally in-
homogeneous increase of activity was evident in most of
the scapula, humerus, radius and in II. shaft on the left,
the highest intensity of changes was in the scapula,
which showed 7-times higher activity compared to the
contra lateral parts. Activity increase in the I. shaft leftFigure 2 CT of cervical spine. Small sclerotic focus is located in
the ventral part of C3 vertebral body - size 7 mm.
Figure 3 Whole body bone scintigraphy. Significant, locally inhomogeneous increase of activity is evident in most of the scapula, humerus,
radius and in II. shaft on the left, the highest intensity of changes are in the scapula, which shows 7-times higher activity compared to the contra
lateral parts. Activity increase in the I. shaft left is more modest and slight accumulation is present in the left medial clavicle and
manubrium sterni.
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in the left medial clavicle (Figure 3). The rest of skeleton
was without significant pathological changes.
DXA examination of the whole skeleton showed osteo-
penia in the lumbar spine: T score −1.2 SD, in both hips
T-score was same and within the normal range. There
was no abnormality found in the laboratory tests includ-
ing bone markers except for increased level of osteocal-
cin and C-terminal telopeptide.
The published cases reported good experience with
bisphosphonate in terms of disease progression [12].
The patient was treated with weekly alendronate and
COX-2 inhibitor (celecoxib). In connection with the de-
velopment of sleep disorders and increased skin sensitiv-
ity sensitivity on affected site naftidrofuryl in high doses
(600 mg daily) was added, which led to symptoms
relieve. The patient is currently without pain and is able
to perform normal daily activities with non-progressive
restriction for 5 years after the diagnosis. Pharmacological
treatment in described combination could delay surgery
solution and eventually could prevent an excessive dosage
of analgetics. Questionable is further development of patient
performance status and sustainability of conservative
treatment in the long term follow up.
Conclusion
X-ray is a sufficient method for diagnosis of melorheos-
tosis. Other imaging techniques are essential for decisionabout therapeutic intervention (CT, MRI, scintigraphy
and DXA). Laboratory findings are usually in physio-
logical range (calcium, phosphorus, markers of bone
formation and resorption, IGF-1). Symptomatic therapy
proved to be sufficient in subjective symptoms manage-
ment. The long term effect of conservative treatment
remains questionable.
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Abbreviation
CT: Computer tomography; MRI: Magnetic resonance imaging; DXA: Dual X-
ray absorptionmetry; SD: Standard deviation.
Competing interest
The authors declare that they have no competing interests.
Authors’ contributions
VV completed all examinations, decided about final diagnosis and and
drafted the manuscript. KK performed first clinical examinations. PT and SK
provided consultation regarding interpretation of imaging methods. All
authors read and approved the final manuscript.
Authors’ information
VV is the head of Center of Metabolic Bone Diseases. His long term scientific
interest is focused on rare bone metabolic diseases and related genetic
disorders. PT is an international expert in orthopaedic traumatology of pelvis
and acetabulum.
Vyskocil et al. BMC Musculoskeletal Disorders  (2015) 16:2 Page 4 of 4Acknowledgement
We would like to express our gratitude to all of our collegues at the
Department of Imaging Methods of Faculty Hospital.
Author details
1Department of Orthopaedic Surgery, Faculty Hospital Plzen, Alej Svobody
80, Plzen 304 60, Czech Republic. 2Department of Imaging Methods, Charles
University Teaching Hospital Plzen and Medical Faculty Plzen, Alej Svobody
80, Plzen 304 60, Czech Republic. 3Department of Clinical Pharmacology,
Charles University Teaching Hospital E. Benese 13, Plzen 30599, Czech
Republic.
Received: 4 May 2014 Accepted: 6 January 2015
References
1. Werner MS, Scheimer RA. Melorheostosis. A review of the literature and
case report. J Am Podiatr Med Assoc. 1987;77(2):96–8.
2. Leri A, Joanny J. Une affection non decrite des os: hyperostose «en coulee»
sur toute la longueur d’un membre ou ‘melorheostose. Bull Mem Soc Med
Hosp Paris. 1922;46:1141–5.
3. Benli IT, Akalin S, Boysan E, Mumcu EF, Kiş M, Türkoğlu D. Epidemiological,
clinical and radiological aspects of osteopoikilosis. J Bone Joint Surg Br.
1992;74(4):504–6.
4. Bansal A. The Dripping Candle Wax Sign. Radiology. 2008;246(2):638–40.
5. Happle R. Melorheostosis may originate as a type 2 segmental
manifestation of osteopoikilosis. Am J Med Genet A. 2004;125A(3):221–3.
6. Murano T, Egarian M. Case report: Emergency department diagnosis of
melorheostosis in the upper extremity: a rare disease with an unusual
presentation. J Emerg Med. 2012;43(4):645–7.
7. Yildirim C, Ozyürek S, Ciçek EI, Kuskucu M. Melorheostosis in the upper
extremity. Orthopedics. 2009;32. Available from: http://www.orthosupersite.
com/view.asp?rID=38064.
8. Jain VK, Arya RK, Bharadwaj M, Kumar S. Melorheostosis: Clinicopathological
Features, Diagnosis, and Management. Orthopedics. 2009;32(7):512–20.
9. Fernandes CH, Nakachima LR, Santos JBG, Fernandes ARC, Jannini MG,
Faloppa F. Melorheostosis of the thumb and trapezium bone. Hand N Y N.
2011;6(1):80–4.
10. Murray RO, McCredie J. Melorheostosis and the sclerotomes: a radiological
correlation. Skeletal Radiol. 1979;4(2):57–71.
11. Fryns JP. Melorheostosis and somatic mosaicism. Am J Med Genet. 1995;58
(2):199.
12. Donáth J, Poór G, Kiss C, Fornet B, Genant H. Atypical form of active
melorheostosis and its treatment with bisphosphonate. Skeletal Radiol.
2002;31(12):709–13. Epub 2002 Oct 29.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
